Univariate analysis of clinicopathological factors associated with clinical outcome in the RT group (n = 30).
- Kazuhiro Kitajima (562836)
- Yuko Suenaga (562837)
- Tomonori Kanda (562838)
- Daisuke Miyawaki (562839)
- Kenji Yoshida (299416)
- Yasuo Ejima (562840)
- Ryohei Sasaki (562841)
- Hirokazu Komatsu (209445)
- Miki Saito (562842)
- Naoki Otsuki (562843)
- Ken-ichi Nibu (562844)
- Naomi Kiyota (562845)
- Tsutomu Minamikawa (562846)
- Kazuro Sugimura (462833)
Publication date
May 2014
DOIAbstract
<p>RT: radiotherapy.</p><p>n: number of patients.</p><p>PFS: progression-free survival.</p><p>LC: local control.</p><p>NPFS: nodal progression-free survival.</p><p>DMFS: distant metastasis-free survival.</p><p>SUVmaximum: maximum standardized uptake value.</p><p>AJCC: American Joint Committee on Cancer.</p
Add to ORKG